InvestorsHub Logo
Followers 30
Posts 1475
Boards Moderated 0
Alias Born 07/10/2013

Re: Nanotoday post# 70090

Wednesday, 07/24/2013 7:16:15 AM

Wednesday, July 24, 2013 7:16:15 AM

Post# of 146235
Good to know you are in.

Projected Milestones for 2013

From the NNVC - RedChip video, the following are events and the projected Milestones for 2013:


-Completion of new Company cGMP/R&D Center in Shelton, CT

-Commission new cGMP plant and begin production of cGMP drugs

-Receive initial results of toxicology studies on FluCide TM

-Prepare IND for submission to regulatory authorities

I'm sure the Project Management group as well as the company that designed the toxicology and safety pharmacology studies were on board with these projected Milestones for 2013. Their reputation is on the line. I believe they will deliver. Company’s survival is dependent on reaching milestones efficiently (in terms of time and money) to successfully raise additional funding. The company has enough money to take them through Phase I/II 2014. How can they achieve the important Phases I/II if the projected Milestones are delayed? Yes, these Milestones are very important and they know it. We know it. Every time we post these news we are holding them accountable and the company is fully aware of that.

Other coming events in 2013:

Patents issued in Australia, Japan, China, the United States and in all of Africa. Twenty five countries thus far. Well over 100 countries should approve patent applications by the end of 2013. These patents were issued as "first in class" with no existing prior art.

I do expect application for DengueCide® orphan status will get approval from regulatory body ~ 2013

Having completed the expected 2013 projected Milestones and others, they will enter a controlled race to Phase I (2014). Anticipation will build and that will be good for all.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News